Adjuvant immunotherapy of feline injection-site sarcomas with the recombinant canarypox virus expressing feline interleukine-2 evaluated in a controlled monocentric clinical trial when used in association with surgery and brachytherapy-Reference-Cited by-同舟云学术

Adjuvant immunotherapy of feline injection-site sarcomas with the recombinant canarypox virus expressing feline interleukine-2 evaluated in a controlled monocentric clinical trial when used in association with surgery and brachytherapy

Published:2015 Issue: Volume:4 Page:1-8
ISSN:1879-4378
Container-title:Trials in Vaccinology
language:en
Short-container-title:Trials in Vaccinology

Author:

Jas D.,Soyer C.,De Fornel-Thibaud P.,Oberli F.,Vernes D.,Guigal P.-M.,Poulet H.,Devauchelle P.

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,Immunology,Microbiology

Reference34 articles.

1. Rounak Nande, Gene transfer in a newly established spontaneous feline fibrosarcoma cell line (Theses, Dissertations and Capstones), Paper 429, 2013.

2. Correlation between perioperative factors and successful outcome in fibrosarcoma resection in cats;Davis;Vet. Rec.,2007

3. Prognosis for presumed feline vaccine associated sarcoma after excision: 61 cases (1986–1996);Hershey;J. Am. Vet. Med. Assoc.,2000

4. Feline injection-site sarcoma: past, present and future perspectives;Martano;Vet. J.,2011

5. Treatment with a combination of doxorubicin, surgery, and radiation versus surgery and radiation alone for cats with vaccine-associated sarcomas: 25 cases (1995–2000);Bregazzi;J. Am. Vet. Med. Assoc.,2001

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ADJUVANT COMBINED SYSTEMIC IMMUNO-CHEMOTHERAPY WITH RECOMBINANT INTERFERON OMEGA AND DOXORUBICIN FIBROSARCOMA INJECTION SITES IN CATS;Themed collection of papers from Foreign international scientific conference «Joint innovation - joint development». Part 2. by HNRI «National development» in cooperation with PS of UA. October 2023. - Harbin (China);2024-01-18

2. Feline Injection-Site Sarcoma and Other Adverse Reactions to Vaccination in Cats;Viruses;2023-08-08

3. Electrochemotherapy Plus IL-2+IL-12 Gene Electrotransfer in Spontaneous Inoperable Stage III–IV Canine Oral Malignant Melanoma;Vaccines;2023-05-27

4. Bortezomib inhibits the proteasome, leading to cell death via apoptosis in feline injection site sarcoma cells in vitro;American Journal of Veterinary Research;2022-05-08

5. ALVAC‐fIL2 , a feline interleukin‐2 immunomodulator, as a treatment for sarcoids in horses: A pilot study;Journal of Veterinary Internal Medicine;2022-04-13